Allows a licensed psychologist to apply to the department of education for conditional prescribing certification if the psychologist meets certain requirements; allows the department of education to waive certain requirements for an applying psychologist; provides that a conditional prescribing certification shall be valid for a period of two years.
This bill would create a new framework in the Education Law allowing certain licensed psychologists in New York to obtain conditional prescribing certification and, after meeting additional experience requirements, full prescriptive authority. Under the bill, a psychologist would need specialized graduate education in clinical psychopharmacology, supervised clinical training, a qualifying exam, malpractice insurance, and other department-set requirements before being allowed to prescribe psychotropic medications. The bill also defines key terms, sets out the scope of medications and related diagnostic tools that may be used, and requires collaboration with a licensed physician, nurse practitioner, psychiatric nurse practitioner, or clinical nurse specialist during the conditional period.
The bill establishes a two-step pathway: a two-year conditional prescribing fellowship with at least 400 hours of clinical training and 100 patients, followed by a certificate of prescriptive authority after two years of supervised prescribing experience. It also requires annual continuing education, DEA registration reporting, department oversight, and rules for renewal, discipline, suspension, or revocation. The State Board for Psychology would be expanded to include at least two prescribing psychologists, and existing law barring psychologists from prescribing drugs would be amended to carve out this new authority.
The bill would significantly amend the Education Law by adding a new section authorizing psychologists to prescribe psychotropic medications under a regulated collaborative model, while also modifying existing provisions that currently prohibit psychologists from prescribing drugs. It would create new licensing, training, supervision, reporting, and disciplinary requirements administered by the State Education Department, and would affect psychologists, collaborating clinicians, patients receiving mental health treatment, and the professional boards overseeing psychology practice. In practice, it would expand the scope of psychology practice in New York and potentially increase access to psychiatric medication management, especially in underserved areas or for patients facing provider shortages.
No committee transcript or vote record was provided, so there is no documented floor or committee debate to gauge formal sentiment. Based on the bill text and caption, the measure appears to be framed as a professional scope-of-practice expansion with extensive safeguards, suggesting a policy approach aimed at balancing access to care with training and oversight. The absence of recorded votes or discussion means there is no available evidence here of support or opposition from legislators in the provided materials.
The main likely point of contention is whether psychologists should be allowed to prescribe psychotropic medications at all, and if so, under what level of training and supervision. Supporters would likely emphasize expanded access to mental health treatment, especially in areas with shortages of psychiatrists and other prescribers, while opponents may raise concerns about patient safety, adequacy of medical training, diagnostic complexity, and overlap with physicians and nurse practitioners. The bill attempts to address these concerns through extensive education requirements, a collaborative prescribing period, malpractice insurance, continuing education, and department oversight, but the scope expansion itself remains the central issue.